Literature DB >> 11398147

Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.

S R Srinivasan1, C Ehnholm, A Elkasabany, G S Berenson.   

Abstract

To elucidate to what extent apolipoprotein (apo) E polymorphism modulates obesity-induced dyslipidemias during young adulthood, longitudinal data on 759 individuals (72% white/28% black; initial and follow-up mean age, 25.9 and 32.7 years) were examined. Among both races and the total sample, the apo E2 group (with E2/2 or E2/3 phenotype) had significantly lower and the apo E4 (with E4/4 or E3/4 phenotype) group higher low-density lipoprotein (LDL) cholesterol than the apo E3 (with E3/3 phenotype) group at both examinations. In addition, the apo E2 group displayed higher high-density lipoprotein (HDL) cholesterol in the total sample. No allele-specific effect was noted for the longitudinal changes (Delta). An increase in Delta adiposity, measured as Delta body mass index (BMI), was accompanied by higher increase in Delta LDL cholesterol in the e4 carriers than the e2 carriers among the whites (P <.05) and the total sample (P <.01); an increase in Delta triglycerides and decrease in Delta HDL cholesterol in the e2 carriers than the e4 carriers among all the groups (P <.05 to.001). Among the apo E phenotype groups, the incidence of high (>75th percentile specific for race and sex) LDL cholesterol at follow-up was in the order E4 > E3 > E2 both in the obese (BMI > 30; P for trend =.033) and the nonobese (BMI < 25; P for trend =.035) groups. Although the increase of low (<25th percentile specific for race and sex) HDL cholesterol or high triglycerides showed no apo E phenotype-specific trend, the incidence of high triglycerides without high LDL cholesterol was in the order E2 > E3 > E4 only in the obese group (P for trend =.025). The prevalence trend for dyslipidemias at follow-up among the persistently obese and nonobese groups also gave similar results. Thus, apo E gene locus influences not only the levels of certain lipoprotein variables during young adulthood, but also modulates the association between obesity and dyslipidemias. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398147     DOI: 10.1053/meta.2001.23299

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

Review 1.  Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps.

Authors:  Liying Corinne Lee; Michele Q L Goh; Edward H Koo
Journal:  Bioessays       Date:  2017-07-21       Impact factor: 4.345

2.  Expression of the human apoE2 isoform in adipocytes: altered cellular processing and impaired adipocyte lipogenesis.

Authors:  Zhi H Huang; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2011-07-08       Impact factor: 5.922

3.  Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients.

Authors:  Filomena Addante; Daniele Sancarlo; Massimiliano Copetti; Carlo Scarcelli; Maria Grazia Longo; Valeria Niro; Giulia Paroni; Fabio Pellegrini; Luigi Fontana; Alberto Pilotto
Journal:  Rejuvenation Res       Date:  2011-04       Impact factor: 4.663

Review 4.  Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.

Authors:  Nikolaos Scarmeas; Yaakov Stern
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

5.  Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy.

Authors:  Leila Kheirandish-Gozal; Oscar Sans Capdevila; Riva Tauman; David Gozal
Journal:  J Clin Sleep Med       Date:  2006-07-15       Impact factor: 4.062

Review 6.  Insulin: an emerging treatment for Alzheimer's disease dementia?

Authors:  Jill K Morris; Jeffrey M Burns
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

7.  Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study.

Authors:  Catherine R Rahilly-Tierney; Donna K Arnett; Kari E North; James S Pankow; Steven C Hunt; R Curtis Ellison; J Michael Gaziano; Luc Djoussé
Journal:  Lipids Health Dis       Date:  2011-09-23       Impact factor: 3.876

8.  Detecting the genetic link between Alzheimer's disease and obesity using bioinformatics analysis of GWAS data.

Authors:  Qi-Shuai Zhuang; Hao Zheng; Xiao-Dan Gu; Liang Shen; Hong-Fang Ji
Journal:  Oncotarget       Date:  2017-07-08

9.  Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study.

Authors:  M Carolina Pardo Silva; A Cecile J W Janssens; Albert Hofman; Jacqueline C M Witteman; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2007-12-28       Impact factor: 8.082

10.  Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality.

Authors:  Sylvia Villeneuve; Diane Brisson; Daniel Gaudet
Journal:  J Lipids       Date:  2015-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.